GB1372812A - Cerebrospinal fluid control standard - Google Patents

Cerebrospinal fluid control standard

Info

Publication number
GB1372812A
GB1372812A GB1444873A GB1444873A GB1372812A GB 1372812 A GB1372812 A GB 1372812A GB 1444873 A GB1444873 A GB 1444873A GB 1444873 A GB1444873 A GB 1444873A GB 1372812 A GB1372812 A GB 1372812A
Authority
GB
United Kingdom
Prior art keywords
cerebrospinal fluid
control standard
per
fluid control
march
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1444873A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of GB1372812A publication Critical patent/GB1372812A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB1444873A 1972-03-24 1973-03-26 Cerebrospinal fluid control standard Expired GB1372812A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23790572A 1972-03-24 1972-03-24

Publications (1)

Publication Number Publication Date
GB1372812A true GB1372812A (en) 1974-11-06

Family

ID=22895733

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1444873A Expired GB1372812A (en) 1972-03-24 1973-03-26 Cerebrospinal fluid control standard

Country Status (8)

Country Link
US (1) US3753925A (de)
JP (1) JPS4931390A (de)
BE (1) BE797081A (de)
CA (1) CA985996A (de)
DE (1) DE2314263C2 (de)
FR (1) FR2185248A5 (de)
GB (1) GB1372812A (de)
ZA (1) ZA731898B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2000288A (en) * 1977-06-10 1979-01-04 Eastman Kodak Co Serum compositions stabilized for lyophilisation and reconstitution
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920580A (en) * 1973-07-12 1975-11-18 Miles Lab Liquid control solution
US3897363A (en) * 1973-08-10 1975-07-29 Baxter Laboratories Inc Blood control standard
US4216117A (en) * 1978-05-15 1980-08-05 Bonderman Dean P Lipoprotein diluent or solution and method useful in the preparation of assay reference materials
US4663295A (en) * 1983-06-29 1987-05-05 Ciba Corning Diagnostics Corp. Estrogen-progesterone control reagents and methods for making same
WO1992015887A1 (en) * 1991-03-07 1992-09-17 Baxter Diagnostics Inc. Biosynthetic cerebrospinal fluid control and method of use

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2000288A (en) * 1977-06-10 1979-01-04 Eastman Kodak Co Serum compositions stabilized for lyophilisation and reconstitution
GB2000288B (en) * 1977-06-10 1982-02-17 Eastman Kodak Co Serum compositions stabilized for lyophilisation and reconstitution
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Also Published As

Publication number Publication date
BE797081A (fr) 1973-07-16
JPS4931390A (de) 1974-03-20
US3753925A (en) 1973-08-21
CA985996A (en) 1976-03-23
FR2185248A5 (de) 1973-12-28
DE2314263C2 (de) 1982-11-25
DE2314263A1 (de) 1973-10-04
ZA731898B (en) 1973-12-19

Similar Documents

Publication Publication Date Title
KR880004819A (ko) 펩티드 제제
AU6264686A (en) Antibody complexes of hapten-modified diagnostic or therapeutic agents
GB1372812A (en) Cerebrospinal fluid control standard
Cohen et al. Ca binding to the human red cell membrane: characterization of membrane preparations and binding sites
Bauriedel et al. Reactions of cyanocobalamin and aquocobalamin with proteins.
GB1418849A (en) Production of antisera
GB1129873A (en) Hemoglobin product and preparation process
Fletcher et al. Immunochemical studies of infectious mononucleosis II. Sodium dodecyl sulfate gel electrophoresis of membrane glycoprotein antigens
Southard et al. Induction of Transmembrane Proton Transfer by Mercurials in Mitochondria: I. ION MOVEMENTS ACCOMPANYING TRANSMEMBRANE PROTON TRANSFER
GB1440626A (de)
GB1396219A (en) Method and reagent for testing blood
GB1282172A (en) Cyanmethemoglobin reagents
ES8900068A1 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
Fantl Thiol groups of blood platelets in relation to clot retraction
Huehns et al. Further studies on the isolation and properties of α-chain sub-units of haemoglobin
GB1294518A (en) Test kit for use in the determination of uric acid in blood serum
GB1377346A (en) Method of and reagent for testing blood
GB1423913A (en) Purification of orgotein
GB1486787A (en) Process for stabilizing protein containing liquids
CA2025315A1 (en) Protein-containing aqueous solutions
Prydz et al. A specific system for the estimation of prothrombin activity
Schmoyer et al. Cystic fibrosis: Effect of media from cultured cystic fibrosis fibroblasts on ATPase activity
ATE80306T1 (de) Mittel zur absorptionsverbesserung von proteinen.
SU637063A1 (ru) Реактив дл определени тироксинсв зывающей способности белков сыворотки крови
Mullins Ion fluxes in dialyzed squid axons

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee